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Breed and Swine Lymphocyte Antigen Haplotype Differences in
Agglutination Titers Following Vaccination with B. Bronchiseptica
Abstract
Genetic differences in immune response to B. bronchiseptica after vaccination with a commercial B.
bronchiseptica bacterin were investigated in 1,069 8-wk-old pigs. These pigs were from 65 litters born in the
spring and 66 litters born in the fall of 1982 and were purebreds from the Chester White (n = 128), Duroc (n
= 281), Hampshire (n = 143), Landrace (n = 309) and Yorkshire (n = 208) breeds. Each litter was raised
separately. Individual pigs were vaccinated im at 4 and 6 wk of age with 2 ml of B. bronchiseptica bacterin. At 8
wk of age, 8 ml of blood were collected from each animal and serum prepared to determine agglutinating
antibody titers against B. bronchiseptica bacterin by a bacterial agglutination method. In addition,
lymphocytes were separated from 1 ml of heparinized blood and used to determine Swine Lymphocyte
Antigen (SLA) haplotypes by using cytotoxic antibodies against the SLA complex. Antisera for 3 SLA
haplotypes were made available by the National Institutes of Health. Results indicated that breed of pig
(P<.01) and dam of pig (P<.01) affected the immune response of the pig after B. bronchiseptica vaccination.
Higher immune response was also associated (P<.05) with one of the SLA haplotypes tested. Heritability
estimates for immune response following vaccination were .10 ± .12 (half-sib) and .42 ± .19 (full-sib). Results
suggest that the relationship of the SLA complex to immune response in the pig and nonadditive genetic and
maternal effects on immune response should be further investigated.
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Summary 
Genetic differences in immune response to 
B. bronchiseptica fter vaccination with a 
commercial B. bronchiseptica bacterin were 
investigated in 1,069 8-wk-old pigs. These pigs 
were from 65 litters born in the spring and 66 
litters born in the fall of 1982 and were pure- 
breds from the Chester White (n = 128), Duroc 
(n = 281), Hampshire (n = 143), Landrace (n = 
309) and Yorkshire (n = 208) breeds. Each 
litter was raised separately. Individual pigs were 
vaccinated im at 4 and 6 wk of age with 2 ml of 
B. bronchiseptica bacterin. At 8 wk of age, 8 ml 
of blood were collected from each animal and 
serum prepared to determine agglutinating 
antibody titers against B. bronchiseptica 
bacterin by a bacterial agglutination method. In 
addition, lymphocytes were separated from 1 
ml of heparinized blood and used to determine 
Swine Lymphocyte Antigen (SLA) haplotypes 
by using cytotoxic antibodies against he SLA 
complex. Antisera for 3 SLA haplotypes were 
made available by the National Institutes of 
Health. Results indicated that breed of pig 
(P<.01) and dam of pig (P<.O1) affected the 
immune response of the pig after B. bronchb 
septica vaccination. Higher immune response 
was also associated (P<.05) with one of the 
SLA haplotypes tested. Heritability estimates 
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for immune response following vaccination 
were .10 + .12 (half-sib) and .42 + .19 (full-sib). 
Results suggest that the relationship of the SLA 
complex to immune response in the pig and 
nonadditive genetic and maternal effects on 
immune response should be further investigated. 
(Key Words: Immune Response, Haplotype, 
Swine Lymphocyte Antigen.) 
I ntroduction 
Selection for disease resistance in livestock 
has largely been ignored by quantitative animal 
breeders (Gavora and Spencer, 1983). Specific 
research in swine has dealt with resistance to E. 
coli diarrhea (Gibbons et al., 1977), resistance 
to atrophic rhinitis (AR) (Elias and Hamori, 
1976; Lundeheim, 1979; Kennedy and Moxley, 
1980) and other respiratory diseases (Lunde- 
helm, 1979). Heritability estimates for resistance 
to AR have ranged from .12 (Kennedy and 
Moxley, 1980) to .42 (Elias and Hamori, 1976). 
The primary etiologic agent associated with AR 
appears to be B. bronchiseptica (Switzer, 
1981). Vaccination has been used in field herds 
since 1977 (Farrington and Switzer, 1979), 
though its effectiveness varies. Genetic differ- 
ences in immune response of pigs to antigens or 
vaccines have been reported for vaccination 
with sheep erythrocytes (Buschmann et al., 
1974), E. coli vaccine (Edfors-Lilja et al., 1981) 
and pseudorabies vaccine (Rothschild et al., 
1984). 
The major histocompatibil ity complex 
(MHC) is a region of the genome originally 
shown to be associated with tissue acceptance 
and rejection after grafting (Snell, 1953). The 
MHC is involved intimately in the immune 
response of animals to foreign antigens (Mc- 
Devitt and Chinitz, 1969; Benacerraf and 
McDevitt, 1972; Biozzi et al., 1979; Klein, 
1979). Researchers have found relationships 
between MHC genotypes and susceptibility to 
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disease in mice (Lilly, 1968), in man (Braun, 
1979; Svejgaard et al., 1981) and in the chicken 
(Nordskog et al., 1977; Pevzner et al., 1981; 
Briles et al., 1983). 
The pig MHC is called the Swine Lympho- 
cyte Antigen (SLA) gene complex and has been 
described in outbred pigs (Vaiman et al., 1970; 
Viza et al., 1970) and in inbred miniature pigs 
(Sachs et al., 1976). Vaiman et al. (1978a,b) 
demonstrated genetic control of immune 
response to hen egg white lysozyme and com- 
plement dependent hemolytic activity. Genetic 
variability at the SLA complex has been ob- 
served in European pigs (Vaiman et al., 1979) 
and in U.S. pigs (Rothschild et al., 1983). 
Numerous haplotypes have been identified 
(Vaiman et al., 1979) but the total number 
is unknown and nomenclature has not yet been 
standardized. 
The objectives of this study were 1) ex- 
amine differences in immune response after 
vaccination with B. bronchiseptica nd 2) 
determine if observed differences in immune 
response were genetic and associated with breed 
or with SLA genotypes, or were environmental. 
Materials and Methods 
Animals. Included in the study were 1,069 
purebred pigs of five breeds from 65 litters 
born in the spring and 66 litters born in the fall 
of 1982 at the Iowa State Bilsland Swine 
Breeding Farm. These pigs were assumed to 
represent at least three (Chester White, Hamp- 
shire) and as many as six (Duroc, Landrace, 
Yorkshire) different pedigree lines within each 
breed. Separate pedigree lines represent lines 
that are unrelated based on pedigree informa- 
tion. Semen and boars have been introduced 
routinely into the herd. This introduction of 
outside germplasm is considered to have made 
arfimals in this herd representative of those 
currently produced in the United States. In 
addition, a herd (12 sows) of miniature swine 
introduced from the National Institutes of 
Health (NIH) (Sachs et al., 1976), and repre- 
senting three lines of pigs homozygous for SLA 
haplotypes a_, c and d_ was used. 
Detection of Bordetella broncbiseptica. An 
inactivated B.bronchiseptica b cterin, Rhinobac 
(Norden Laboratories, Lincoln, Nebraska), 
licensed by the USDA in 1977, was used as the 
immunogen. Two milliliters of Rhinobac were 
given im to each pig at 4 wk and at 6 wk of age. 
Sows were not vaccinated, and no symptoms of 
AR existed in the herd. Eight milliliters of 
whole blood were collected from the young 
pigs at 8 wk of age for determination f anti- 
bodies specific to B. bronchiseptica vaccine. 
Eight milliliters of blood were also collected 
from their dams at the same time their off- 
spring were bled. Sera were prepared and stored 
in aliquots at -20  C until use. Serological 
evaluation of the pigs for antibodies against 
B. bronchiseptica was performed by bacterial 
agglutination using a microtitration system. The 
bacterial suspension used as the antigen in the 
serum-agglutination test was prepared from B. 
bronchiseptica t Norden Laboratories and 
shipped to Iowa State University. Fifty micro- 
liters of phosphate buffered saline (PBS) 
containing .01% fetal bovine serum were used 
as diluent for each serum sample. Then, 50/J1 
of serum were added and a twofold dilution 
scheme was done in duplicate in 12-well V 
bottom microtiter plates. Fifty microliters of 
antigen suspension were added to each well of 
the serum dilution to give a final dilution 
scheme of 1:2 to 1:4,096. Plates were covered 
and the serum-bacterial mixture shaken by a 
mechanical shaker for 2 rain. The mixture was 
then incubated at 36 C for 2 h in a humidified, 
5% CO2 incubator. After incubation, plates 
were stored at 4 C for 18 to 24 h. Serum- 
agglutination antibody titers were recorded 
after the cold storage period. The end point 
dilution was chosen as the highest dilution of 
serum that produced at least partial aggluti- 
nation. 
Determination of SLA Haplotype. Three 
different anti-SLA haplotype antisera from 
miniature swine were obtained from the NIH 
and used for this project. These anti-SLA 
haplotype sera were anti- _a (cd ~ aa), anti- c fad 
oc ac) and anti- d_ (ac oc ad). These antisera were 
produced by full thickness skin grafting be- 
tween miniature swine (Leight et al., 1977). 
Antisera were stored undiluted in 50-~1 aliquots 
and stored at -80  C. Normal serum from 
miniature swine was pooled and used as a 
negative control. Rabbit anti-pig xenoantiserum 
was used as a positive control. Antisera were 
diluted in PBS and used at a 1:8 dilution. 
One-milliliter peripheral heparinized blood 
samples were obtained from the retro-orbital 
plexus of piglets and from the anterior vena 
cava of the mature sows. The blood as diluted 
with an equal volume of EGTA-saline [ethyl- 
eneglycol-bis-(fl-aminoethyl ether) N,N,N',N'- 
tetraacetic acid], pH 7.0, and .5 ml layered over 
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1 ml Ficoll-Hypaque at a density of 1.080. 
The samples were centrifuged (12,000 x g, 3 
min, Beckman microfuge), the interphase cells 
collected, and the cells washed once in .01% 
EGTA-saline and once in PBS. Contaminating 
erythrocytes were lysed by treatment with 
Tris-ammonium chloride (.16 M NH4CI in .17 
M Tris buffer, pH 7.2) for 4 min at 37 C. The 
cells were washed three times in PBS, then 
adjusted to 2 x 106 cells/ml in RPMI 1640 
medium supplemented with L-glutamine, 25 
mM HEPES buffer and 10% heat inactivated 
fetal bovine serum (all from GIBCO, New 
York). 
The standard NIH lymphocyte microcyto- 
toxicity test (NIH, 1979--80) was used. The 
assay was performed in Terasaki microtest trays 
(Falcon 3034). Plates were prepared in advance 
by placing about 2 ~ul of oil into each well, 
overlaying with 1/J1 of the appropriate antisera 
and centrifuging to place antisera under the oil. 
Plates were stored at -80  C up to 3 mo be- 
fore use. Plates were thawed just before use. 
One microliter of cell suspension was added to 
each well, after which the plates were centri- 
fuged and incubated at room temperature for 
30 min. Five microliters of guinea pig serum 
(complement) at a 1:4 dilution in PBS was 
added, followed by further incubation at room 
temperature for 60 min. Guinea pig serum 
(stored at -80  C) was used as complement and 
was screened such that there was no nonspecific 
cytotoxicity with the negative control serum 
and nearly 100% cytotoxicity with the positive 
control serum. The reaction was stopped by 
adding 2% EDTA, pH 7.0, to fill each well to 
roundness. The results were read microscopic- 
ally and duplicate samples averaged. The 
scoring system is in table 1. 
Statistical Analysis. B. bronchiseptica g- 
glutination titers were transformed to log2 
values (because serial doubling dilutions had 
been used) to normalize the distribution. Data 
were then analyzed by using the basic model: 
TABLE 1. SCORING OF CYTOTOXICITY TEST 
Approximate 
percentage 
cytotoxicity Score Interpretation 
> 5 0 3 strongly positive 
30 to 50 2 moderately positive 
< 3 0 i negative 







dlk j = 
eijklm = 
the agglutination titer of the pig, 
overall constant, 
fixed effect of the i th year-season, 
fixed effect of the jth breed, 
random effect of the k th sire as- 
sumed to be N(O,o~), 
random effect of the I th dam with- 
in the k th sire and jth breed as- 
sumed to be N(O,a~) and 
random residual assumed to be 
N(O,og). 
Sire, dam and residual effects were assumed to 
be independent. Additional models included 
the effects of the three SLA haplotypes (_a, c~ 
d), as determined by the cytotoxic test results 
(negative, moderately positive and strongly 
positive). Tests of significance (F-tests) for 
breed effects were tested with the sire mean 
square used as the error term, and sires were 
tested with the dam mean square as the error 
term. All other effects were tested by using the 
residual mean square. All F-tests were approxi- 
mate. Estimable functions of the fixed effects 
(least-squares means) were also computed for 
the effects of breed and SLA haplotype. 
A preliminary analysis using a model that 
ignored dams within sires and regressed pig's 
postvaccination titer on dam's natural titer was 
examined. The regression of pig's titer on dam's 
titer was not significant and so the effect was 
replaced by dams within sires. 
Estimates of components of variance for 
^2 sires (~s2), dams (~)  and residual (ge) were 
made by Henderson's Method III (Henderson, 
1953). Heritabilities were estimated as 
~2 (half-sib) = 4~s2/(bg + ~ + Og) and 
~2 (full-sib) = 2(Os 2 + ~)/ (Og + ~ + ~2e). 
Approximate standard errors of ~2 were cal- 
culated by using the formula suggested by 
Graybill et al. (1956). 
Results 
The distribution of B. bronchiseptica g- 
glutination titers after vaccination in each breed 
is in figure 1. Titers were transformed previ- 
ously into log2 values. Breed differences were 
observed with Chester White pigs having the 
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Figure 1. The distribution of B. bronchiseptica 
agglutination titers in each breed. The titers have been 
transformed into log 2 values. 
highest frequency of titer values I> 3. Duroc and 
Hampshire pigs had the greatest frequency of 
titers < 2. 
Results of the analysis of variance of factors 
affecting immune response after vaccination are 
presented in table 2, All models included the 
factors of breed, sire/breed, dam/sire/breed and 
season. Breed effects were all highly significant 
(P<.01). Differences among breeds can be seen 
in table 3. Chester White pigs had significantly 
higher postvaccination titers than did the other 
breeds. Yorkshire and Landrace were ranked 
intermediately and were different (P<.01) from 
Duroc and Hampshire, which had the lowest 
responses. 
Dam within sire effects were highly signifi- 
cant, suggesting that litter effects influenced 
immune response in pigs following vaccination. 
In addition, titers were significantly higher in 
the fall than in the spring. 
Models 2 to 8 contained at least one of the 
SLA haplotypes. With dam/sire in the model, 
haplotype effects were, in effect, within litter 
and pooled across litters. The SLA a_ haplotype 
appears to be significantly (P<.05) associated 
with higher immune response (table 4) but the 
change in R 2 was small. Estimates of immune 
response for those pigs positive for the a 
haplotype were significantly higher than for 
those pigs that were negative for the a_ haplo- 
type. No other haplotype appears to be related 
to immune response after vaccination with B. 
bronchiseptica. 
Estimates of heritability of immune response 
after vaccination are presented in table 5. 
Paternal half-sib estimates of heritability are a 
function of additive gene variation primarily, 
while full-sib estimates reflect additive and 
dominant genetic components as well as ma- 
ternal effects and common litter effects. 
Results indicate low additive variation but 
possibly large dominance, maternal or common 
litter environmental effects. 
Discussion 
The animal's immune response system helps 
provide a defense against disease. Breed differ- 
ences in immune response to a pseudorabies 
vaccine have been reported (Rothschild et al., 
1984). Results here point to large breed effects 
on immune response after challenge by vaccina- 
tion with B. bronchiseptica. Breeds ranked 
from highest response to lowest response 
were Chester White, Yorkshire, Landrace, 
Duroc and Hampshire. High immune response 
following vaccination is associated with higher 
protection (Norden Laboratories, personal 
communication). This study provides no 
information on protection results. The primary 
causative agent of AR is B. bronchiseptica, nd 
turbinate damage often occurs from infection 
(Switzer, 1981). In Minnesota test station data 
(Straw et al., 1983), degree of turbinate damage 
was measured in the five breeds of pigs used in 
this study. Straw et al. (1983) ranked pigs from 
least turbinate damage to greatest damage and 
reported that Duroc, Hampshire and Yorkshire 
pigs had significantly more turbinate damage 
than did Chester White and Landrace pigs. This 
breed ranking for immune response is similar to 
that seen in our study. Gavora and Spencer 
(1983) suggest hat perhaps measuring vaccina- 
tion titers could be useful in identifying resistant 
animals. 
Dam (litter) effects were highly significant. 
Because sire effects were small, this suggests 
that dominance gene effects, maternal effects 
of common environment might play a role in the 
immune response to B. bronchiseptica. Certain- 
ly colostrum from the dam plays a role in 
providing protection for the pig early in life. 
These pigs were vaccinated at 4 and 6 wk 
and were bled at 8 wk of age. Maternal anti- 
bodies should have been low after 4 wk of age. 
Litters lived together and were bled and vacci- 
nated on the same day. This may have con- 
tributed to litter differences. 
Season differences, which may reflect 
temperature differences, were also highly 
significant. It should be noted, however, 
that many aspects in the laboratory analyses 
were confounded with season, such as person- 
nel, antigen source and complement. Though 
no obvious signs of AR existed at the farm, B. 
bronchiseptica is known to be present on most 
swine farms in the United States (Switzer, 
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TABLE 3. BREED LEAST-SQUARES MEANS AND 
STANDARD ERRORS OF B. BRONCHISEPTICA 
AGGLUTINATION TITERS AFTER VACCINATION 
TABLE 5. HERITABILITY ESTIMATES OF 
IMMUNE RESPONSE AFTER VACCINATION 
WITH B. BRONCHISEPTICA 
Breed ~a SE Method h 2 SE a 
Chester White 2.87 b .12 
Duroc 1.90 c .09 
Hampshire 1.84 c .15 
Landrace 2.29 d .08 
Yorkshire 2.37 d .08 
Paternal half-sib .10 .12 
Full-sib .42 .19 
astandard errors are approximate. 
aMean of agglutination titers in log 2 units. 
b'c'dMeans in the same column with no common 
superscripts differ (P<.O1). 
1981). Changes in indigenous B. bronchiseptica 
levels may have also occurred at low levels 
at the farm. However, all prevaccination titers 
were essentially negative. 
It is known that the MHC plays an intimate 
role in the immune response system by coding 
for three classes of molecules (class I, class II, 
class III; Hood et al., 1983). The class I mole- 
cules are believed to be involved in response to 
viral infections. Class II molecules are products 
of the immune response genes, which control 
the magnitude of  the immune response. The 
class III molecules are components of  serum 
complement that are involved in the protection 
of animals against disease. Therefore, it seems 
reasonable that identif ication of MHC geno- 
types associated with high immune response 
might be useful in planning future breeding 
programs for disease resistance. Of particular 
interest, therefore, was the result that the 
presence of the a_ SLA haplotype resulted in 
higher immune response after vaccination. 
Linkage of the SLA gene complex with immune 
TABLE 4. SLA a_HAPLOTYPE LEAST-SQUARES 
MEANS AND STANDARD ERRORS OF B. 
BRONCHISEPTICA AGGLUTINATION TITERS 
AFTER VACCINATION 
Test for a haplotype ~ a SE 
Negative 1.96 b .05 
Moderately positive 2.25 c .09 
Strongly positive 2.34 c .08 
aMean of agglutination titers in log 2 units. 
b'CMeans in the same column with no common 
superscripts differ (P<.05). 
response genes for hen egg white lysozyme has 
already been reported (Vaiman et al., 1978b). 
Steinman et al. (1982) also reported that 
resistance to Bordetella pertussis vaccine 
encephalopathy was associated with the mouse 
MHC. Our results show that the many elegant 
studies on mice and man, linking the MHC with 
disease resistance, can be applied to domestic 
species such as the pig. Further research may 
lead to the selection of pigs more resistant o 
particular diseases, on the basis of their SLA 
haplotypes. 
Conclusions 
The results reported in this paper suggest 
that the immune response of pigs to vaccination 
with Bordetella bronchiseptica is influenced by 
genes in the major histocompatibi l i ty complex. 
Higher immune response was found to be 
associated with the SLA a_ haplotype. Breed 
differences in immune response were also found 
and suggest that the usefulness of vaccines 
may vary from breed to breed and that vaccine 
trials should consider this source of variation. 
Furthermore, it was suggested that additive, 
dominance and maternal effects may influence 
the immune response. Crossbreeding and cross- 
fostering experiments should be helpful in 
elucidating the mechanisms of these effects. 
Finally, the development of  typing reagents to 
detect more SLA haplotypes would be helpful 
in examining SLA associations with disease 
resistance or improved immune response. 
Continuation of such research could provide 
useful information to ascertain the potential of 
selecting pigs more resistant o specific diseases. 
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